We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1501
American Assets Trust
AAT
$1.39B
| $27.1K | ﹤0.01% |
1,430
+358
| +33% | +$6.91K |
|
|
DEA
1502
Easterly Government Properties
DEA
$1.16B
| $26.7K | ﹤0.01% |
1,259
+324
| +35% | +$7.03K |
|
1503
Design Therapeutics
DSGN
$917M
| $26K | ﹤0.01% |
2,768
+566
| +26% | +$4.43K |
|
1504
Teradata
TDC
$2.49B
| $25.9K | ﹤0.01% |
852
-123
| -13% | -$3.22K |
|
|
DAO
1505
Youdao
DAO
$2.23B
| $25.6K | ﹤0.01% |
2,535
| – | – |
|
1506
Absci
ABSI
$1.61B
| $25.5K | ﹤0.01% |
7,307
+1,526
| +26% | +$5.56K |
|
1507
Vanda Pharmaceuticals
VNDA
$314M
| $25.3K | ﹤0.01% |
2,872
+588
| +26% | +$3.24K |
|
1508
Prothena Corp
PRTA
$475M
| $25K | ﹤0.01% |
2,616
+535
| +26% | +$5.45K |
|
1509
Zevra Therapeutics
ZVRA
$679M
| $24.5K | ﹤0.01% |
2,736
+566
| +26% | +$5.35K |
|
|
EH
1510
EHang Holdings
EH
$432M
| $24.5K | ﹤0.01% |
1,859
+42
| +2% | +$663 |
|
|
LENZ
1511
LENZ Therapeutics
LENZ
$158M
| $24.3K | ﹤0.01% |
1,520
+417
| +38% | +$12.2K |
|
|
PLYM
1512
DELISTED
Plymouth Industrial REIT
PLYM
| $24.2K | ﹤0.01% |
1,107
+209
| +23% | +$4.59K |
|
|
DHC
1513
Diversified Healthcare Trust
DHC
$2.02B
| $24K | ﹤0.01% |
4,939
+1,239
| +33% | +$5.62K |
|
1514
GameStop
GME
$8.32B
| $23.8K | ﹤0.01% |
+1,185
| New | +$26.6K |
|
1515
China Yuchai International
CYD
$1.76B
| $23.8K | ﹤0.01% |
670
| – | – |
|
|
AIV
1516
Aimco
AIV
$379M
| $23.5K | ﹤0.01% |
3,951
+1,002
| +34% | +$6K |
|
1517
Booz Allen Hamilton
BAH
$9.43B
| $23.3K | ﹤0.01% |
276
-24,333
| -99% | -$2.18M |
|
1518
Gentex
GNTX
$4.93B
| $23.1K | ﹤0.01% |
991
-346
| -26% | -$8.34K |
|
|
BIOA
1519
BioAge Labs
BIOA
$481M
| $23K | ﹤0.01% |
+1,742
| New | +$15.4K |
|
|
MOMO
1520
Hello Group
MOMO
$867M
| $23K | ﹤0.01% |
3,506
-14
| -0.4% | -$96 |
|
|
LKFT
1521
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $23K | ﹤0.01% |
702
+148
| +27% | +$4.78K |
|
1522
Maravai LifeSciences
MRVI
$861M
| $22.9K | ﹤0.01% |
7,047
+1,454
| +26% | +$4.89K |
|
|
FINV
1523
FinVolution Group
FINV
$1.07B
| $22.6K | ﹤0.01% |
4,317
+57
| +1% | +$335 |
|
|
RERE
1524
ATRenew
RERE
$988M
| $22.6K | ﹤0.01% |
+4,256
| New | +$19.1K |
|
1525
Iridium Communications
IRDM
$5.26B
| $22.3K | ﹤0.01% |
+1,285
| New | +$22.7K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.